ES8608313A1 - Procedimiento para preparar microcapsulas con liberacion controlada de la substancias activa, que contienen peptidos,reguladores y un material de soporte biologicamente degradable. - Google Patents

Procedimiento para preparar microcapsulas con liberacion controlada de la substancias activa, que contienen peptidos,reguladores y un material de soporte biologicamente degradable.

Info

Publication number
ES8608313A1
ES8608313A1 ES545723A ES545723A ES8608313A1 ES 8608313 A1 ES8608313 A1 ES 8608313A1 ES 545723 A ES545723 A ES 545723A ES 545723 A ES545723 A ES 545723A ES 8608313 A1 ES8608313 A1 ES 8608313A1
Authority
ES
Spain
Prior art keywords
microcapsules
controlled release
preparation
regulatory peptides
injectable formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES545723A
Other languages
English (en)
Other versions
ES545723A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of ES8608313A1 publication Critical patent/ES8608313A1/es
Publication of ES545723A0 publication Critical patent/ES545723A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/06—Making microcapsules or microballoons by phase separation
    • B01J13/12—Making microcapsules or microballoons by phase separation removing solvent from the wall-forming material solution
    • B01J13/125—Making microcapsules or microballoons by phase separation removing solvent from the wall-forming material solution by evaporation of the solvent

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR MICROCAPSULAS CON LIBERACION CONTROLADA DE LA SUSTANCIA ACTIVA. COMPRENDE: A) EMULSIONAR UNA SOLUCION ACUOSA DEL PEPTIDO REGULADOR EN UNA SOLUCION DEL PHB, EN UN HIDROCARBURO DE C 1 A 4 ALIFATICO HALOGENADO Y ENTRE 0 Y 50JC; B) AÑADIR A LA EMULSION DE A) ACEITE DE SILICONA, PARA RODEAR A LAS GOTAS DE EMULSION POR LA ENVOLTURA DE PHB Y FORMAR MICROCAPSULAS CON UN TAMAÑO DE 200 MM EN SOLUCION; C) FILTRAR A LA SOLUCION DE B), PARA SEPARAR A LAS MICROCAPSULAS; Y D) TRATAR A LAS MICROCAPSULAS CON HIDROCARBUROS SATURADOS PARA ENDURECERLOS. LOS PEPTIDOS REGULADORES SE ELIGEN ENTRE OXITOCINA, VASOPRESINA, HORMONA ADRENO CORTICOTROPA, GASTRINA Y SECRETINA; EL HIDROCARBURO ALIFATICO HALOGENADO, SE ELIGE ENTRE CLOROFORMO Y CLORURO DE METILENO; EL HIDROCARBURO SATURADO PARA ENDURECER A LAS MICROCAPSULAS SE ELIGE ENTRE ETER DE PETROLEO HEPTANO O PENTANO. SIENDO PHB POLIACIDO D(-)-3-HIDROXIBUTIRICO. SE UTILIZAN PARA EL TRATAMIENTO DEL CARCINOMA DE MAMA, DE LA ENDOMETRIOSIS Y DE LA PUBERTAD PRECOZ.
ES545723A 1984-08-01 1985-07-30 Procedimiento para preparar microcapsulas con liberacion controlada de la substancias activa, que contienen peptidos,reguladores y un material de soporte biologicamente degradable. Expired ES8608313A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843428372 DE3428372A1 (de) 1984-08-01 1984-08-01 Mikrokapseln von regulatorischen peptiden mit kontrollierter freisetzung, verfahren zu ihrer herstellung und injektionszubereitungen

Publications (2)

Publication Number Publication Date
ES8608313A1 true ES8608313A1 (es) 1986-07-01
ES545723A0 ES545723A0 (es) 1986-07-01

Family

ID=6242124

Family Applications (1)

Application Number Title Priority Date Filing Date
ES545723A Expired ES8608313A1 (es) 1984-08-01 1985-07-30 Procedimiento para preparar microcapsulas con liberacion controlada de la substancias activa, que contienen peptidos,reguladores y un material de soporte biologicamente degradable.

Country Status (12)

Country Link
EP (1) EP0172422A3 (es)
JP (1) JPS6143119A (es)
KR (1) KR860001592A (es)
AU (1) AU4567785A (es)
DE (1) DE3428372A1 (es)
DK (1) DK348185A (es)
ES (1) ES8608313A1 (es)
GR (1) GR851872B (es)
HU (1) HU195108B (es)
IL (1) IL75936A0 (es)
PT (1) PT80890B (es)
ZA (1) ZA855769B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3712095A1 (de) * 1987-04-10 1988-10-20 Lentia Gmbh Bindemittelfreies granulat mit verzoegerter wirkstoffabgabe
NZ224549A (en) * 1987-05-29 1990-04-26 Ici Australia Operations Controlled release polymer microspheres containing at least one active agent
JP2837675B2 (ja) * 1987-09-22 1998-12-16 中外製薬株式会社 徐放性微粒製剤
DE3738228A1 (de) * 1987-11-11 1989-05-24 Hoechst Ag Verfahren zur herstellung von bioabbaubaren mikrokapseln wasserloeslicher peptide und proteine sowie nach diesem verfahren erhaltene mikrokapseln
EP0429832B1 (de) * 1989-11-30 1994-06-22 PCD-Polymere Gesellschaft m.b.H. Nicht wirkstoffretardierender Pressling, Verfahren zu dessen Herstellung und Verwendung von Polyhydroxybuttersäure zur Herstellung eines solchen Presslings
JP2997488B2 (ja) * 1989-12-25 2000-01-11 興研株式会社 腫瘍細胞増殖抑制剤
DE4000155A1 (de) * 1990-01-04 1991-07-11 Chemie Linz Deutschland Nicht wirkstoffretardierender pressling, verfahren zu dessen herstellung und verwendung von polyhydroxybuttersaeure zur herstellung eines solchen presslings
CA2046830C (en) * 1990-07-19 1999-12-14 Patrick P. Deluca Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer
DE4041563A1 (de) * 1990-12-22 1992-06-25 Sanol Arznei Schwarz Gmbh Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren
JPH0580599U (ja) * 1992-04-03 1993-11-02 株式会社丸島アクアシステム 閉鎖系水域における水質浄化装置
DE4223169C1 (de) 1992-07-10 1993-11-25 Ferring Arzneimittel Gmbh Verfahren zur Mikroverkapselung wasserlöslicher Wirkstoffe
DE4427201C2 (de) * 1993-11-26 1996-09-12 Ges Innenhochdruckverfahren Verfahren zur Herstellung von hohlen Nockenwellen
CN1278675C (zh) 2001-07-10 2006-10-11 佳能株式会社 含聚羟基烷醇酸酯的粒状体及其制备方法
JP2004331750A (ja) 2003-05-02 2004-11-25 Canon Inc ポリヒドロキシアルカノエートを含有する磁性構造体及びその製造方法ならびにその用途
GB2470378A (en) * 2009-05-20 2010-11-24 Univ Westminster A controlled release composition for intraocular delivery of a therapeutic agent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH649217A5 (de) * 1977-08-25 1985-05-15 Sandoz Ag Bromocriptin enthaltende mikrokapseln.
PH19942A (en) * 1980-11-18 1986-08-14 Sintex Inc Microencapsulation of water soluble polypeptides
GB2108074A (en) * 1981-10-28 1983-05-11 Pa Management Consult Preservation and projection of active substances

Also Published As

Publication number Publication date
ZA855769B (en) 1986-03-26
DK348185D0 (da) 1985-07-31
HUT41982A (en) 1987-06-29
HU195108B (en) 1988-04-28
ES545723A0 (es) 1986-07-01
DK348185A (da) 1986-02-02
EP0172422A2 (de) 1986-02-26
AU4567785A (en) 1986-02-06
DE3428372A1 (de) 1986-02-13
PT80890B (de) 1987-03-24
IL75936A0 (en) 1985-12-31
EP0172422A3 (de) 1986-05-07
GR851872B (es) 1985-12-02
KR860001592A (ko) 1986-03-20
PT80890A (de) 1985-08-01
JPS6143119A (ja) 1986-03-01

Similar Documents

Publication Publication Date Title
ZA852639B (en) Implantable formulations of regulatory peptides with controlled release,and process for their preparation
ES8608313A1 (es) Procedimiento para preparar microcapsulas con liberacion controlada de la substancias activa, que contienen peptidos,reguladores y un material de soporte biologicamente degradable.
IL102848A0 (en) Polypeptides having growth hormone releasing activity,their use and pharmaceutical compositions containing them
EP0326618A4 (en) MEDICAL COMPOSITION, WHICH CONTAINS ALBUMIN AS A CARRIER, AND METHOD FOR THE PRODUCTION THEREOF.
NZ227788A (en) Peptide having growth hormone regulatory effects, and compositions
IL76440A0 (en) Growth hormone releasing factor analogs,their preparation and pharmaceutical compositions containing them
GB2198134B (en) Substituted a-amino acids, their preparation and pharmaceutical compositions containing them
JPS6470473A (en) Novel imidazolidine substituted with hydroxymethyl group and substituted phenyl group, manufacture, use as drug, pharmaceutical composition and intermediate
EG18379A (en) Novel pharmacological compounds
ZA938791B (en) Method and pharmaceutical preparations for reducing the activity of cells.
KR0180256B1 (en) Bpc peptides, their preparation and use
GB2156818B (en) Substituted a-amino acids, their preparation and pharmaceutical compositions containing them
ZA884622B (en) Pharmaceutical compositions in the form of pellets with enzymatically controlled release of the pharmaceutical,substance
IE870239L (en) Recombinant interleukin-2-composition
HUT42296A (en) Growth regulating compositions containing acetic acid derivatives containing phosphor as active ingredients and process for preparing the active ingredients
EP0168042A3 (en) Dihydroorotic acid derivatives, processes for their preparing and pharmaceutical composition containing them
PH27586A (en) Low molecular weight derivatives of proukokinase pharmaceutical composition containing the same and method of use thereof
IL85651A0 (en) Optically active oxo-isoindolinyl derivatives,their preparation and pharmaceutical compositions containing them
EP0175323A3 (en) Biologically active peptides, processes for preparing them and pharmaceutical compositions
JPS6442470A (en) Guanidinecarboxylic acid esters, manufacture and medicinal composition
IL75607A0 (en) Phosphoric acid esters,their preparation and their use as pesticides
AU7927987A (en) Pharmaceutical peptide compositions, also containing poly-d-3-hydroxybutyric acid and calcium acetate/glycerol adduct
ZA854330B (en) Insulin formulations,processes for their preparation and their use
GR3000615T3 (en) Substituted phenyl acid esters, their preparation and their use as insecticides and acaricides
ES2001042A6 (es) Un metodo para la preparacion de acidos 5,6-dialcoxiantranilicos